Dr. Mutamba leads corporate strategy, business development, investor relations and finance at Arrakis. He has broad experience in company formation, strategy and growth in the biotech and life sciences industry. Prior to joining Arrakis, Dr. Mutamba was Vice President of Business and Corporate Development at Pyxis Oncology (Nasdaq: PYXS) where he was responsible for leading strategy and business development for the company culminating in a worldwide licensing agreement with Pfizer and financing transactions, including the company’s Series B financing and subsequent initial public offering. Prior to Pyxis Oncology, Dr. Mutamba was a Principal at Longwood Fund, where he built and supported portfolio companies. Previously, he was a Senior Associate at PureTech Health where he was a co-founder of Commense, Inc., and was a co-founder and inventor of Glyph Biosciences and Calix Biopharma (now Orasome). Earlier in his career, Dr. Mutamba was a strategy consultant and played multiple roles in research and product development at Pathogenica, Inc., a biotech startup out of Harvard University. He received his BS in Biochemistry from University of North Carolina at Greensboro, and earned his PhD from MIT in the Department of Biological Engineering and completed coursework at the MIT Sloan School of Management.